Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$0.24 - $0.52 $519,906 - $1.13 Million
2,166,279 Added 145.31%
3,657,058 $1.24 Million
Q4 2022

Feb 13, 2023

SELL
$0.22 - $1.04 $49,362 - $233,348
-224,374 Reduced 13.08%
1,490,779 $387,000
Q3 2022

Nov 14, 2022

BUY
$0.25 - $2.4 $18,976 - $182,169
75,904 Added 4.63%
1,715,153 $1.51 Million
Q2 2022

Aug 15, 2022

BUY
$1.22 - $3.05 $1.24 Million - $3.09 Million
1,012,945 Added 161.73%
1,639,249 $2.07 Million
Q1 2022

May 13, 2022

BUY
$2.64 - $4.67 $41,046 - $72,609
15,548 Added 2.55%
626,304 $1.92 Million
Q4 2021

Feb 11, 2022

BUY
$4.4 - $8.8 $32,731 - $65,463
7,439 Added 1.23%
610,756 $2.72 Million
Q3 2021

Nov 16, 2021

BUY
$7.44 - $13.99 $4.49 Million - $8.44 Million
603,317 New
603,317 $4.58 Million

Others Institutions Holding SMFR

About Sema4 Holdings Corp.


  • Ticker SMFR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 380,641,984
  • Market Cap $129M
  • Description
  • Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...
More about SMFR
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.